178 related articles for article (PubMed ID: 24498068)
1. Mitogen-induced B-cell proliferation activates Chk2-dependent G1/S cell cycle arrest.
Nikitin PA; Price AM; McFadden K; Yan CM; Luftig MA
PLoS One; 2014; 9(1):e87299. PubMed ID: 24498068
[TBL] [Abstract][Full Text] [Related]
2. Sustained CHK2 activity, but not ATM activity, is critical to maintain a G1 arrest after DNA damage in untransformed cells.
García-Santisteban I; Llopis A; Krenning L; Vallejo-Rodríguez J; van den Broek B; Zubiaga AM; Medema RH
BMC Biol; 2021 Feb; 19(1):35. PubMed ID: 33607997
[TBL] [Abstract][Full Text] [Related]
3. Rotavirus activates a noncanonical ATM-Chk2 branch of DNA damage response during infection to positively regulate viroplasm dynamics.
Sarkar R; Patra U; Lo M; Mukherjee A; Biswas A; Chawla-Sarkar M
Cell Microbiol; 2020 Mar; 22(3):e13149. PubMed ID: 31845505
[TBL] [Abstract][Full Text] [Related]
4. Activation of ATM/Chk2 by Zanthoxylum armatum DC extract induces DNA damage and G1/S phase arrest in BRL 3A cells.
Jiang J; Huang Y; Wang W; Sun C; Liu Q; Chen Y; Hu T; Ma X; Peng C; Ma Y; Liu S; Rao C
J Ethnopharmacol; 2022 Feb; 284():114832. PubMed ID: 34775036
[TBL] [Abstract][Full Text] [Related]
5. An ATM/Chk2-mediated DNA damage-responsive signaling pathway suppresses Epstein-Barr virus transformation of primary human B cells.
Nikitin PA; Yan CM; Forte E; Bocedi A; Tourigny JP; White RE; Allday MJ; Patel A; Dave SS; Kim W; Hu K; Guo J; Tainter D; Rusyn E; Luftig MA
Cell Host Microbe; 2010 Dec; 8(6):510-22. PubMed ID: 21147465
[TBL] [Abstract][Full Text] [Related]
6. STAT3 interrupts ATR-Chk1 signaling to allow oncovirus-mediated cell proliferation.
Koganti S; Hui-Yuen J; McAllister S; Gardner B; Grasser F; Palendira U; Tangye SG; Freeman AF; Bhaduri-McIntosh S
Proc Natl Acad Sci U S A; 2014 Apr; 111(13):4946-51. PubMed ID: 24639502
[TBL] [Abstract][Full Text] [Related]
7. Patterns of DNA damage response in intracranial germ cell tumors versus glioblastomas reflect cell of origin rather than brain environment: implications for the anti-tumor barrier concept and treatment.
Bartkova J; Hoei-Hansen CE; Krizova K; Hamerlik P; Skakkebæk NE; Rajpert-De Meyts E; Bartek J
Mol Oncol; 2014 Dec; 8(8):1667-78. PubMed ID: 25066726
[TBL] [Abstract][Full Text] [Related]
8. Extremely low-frequency electromagnetic fields cause G1 phase arrest through the activation of the ATM-Chk2-p21 pathway.
Huang CY; Chang CW; Chen CR; Chuang CY; Chiang CS; Shu WY; Fan TC; Hsu IC
PLoS One; 2014; 9(8):e104732. PubMed ID: 25111195
[TBL] [Abstract][Full Text] [Related]
9. Modelling the onset of senescence at the G1/S cell cycle checkpoint.
Mombach JC; Bugs CA; Chaouiya C
BMC Genomics; 2014; 15 Suppl 7(Suppl 7):S7. PubMed ID: 25573782
[TBL] [Abstract][Full Text] [Related]
10. Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer: a crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation.
Chang WL; Hsu LC; Leu WJ; Chen CS; Guh JH
Oncotarget; 2015 Nov; 6(37):39806-20. PubMed ID: 26447757
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitor chidamide induces growth inhibition and apoptosis in NK/T lymphoma cells through ATM-Chk2-p53-p21 signalling pathway.
Zhou J; Zhang C; Sui X; Cao S; Tang F; Sun S; Wang S; Chen B
Invest New Drugs; 2018 Aug; 36(4):571-580. PubMed ID: 29504068
[TBL] [Abstract][Full Text] [Related]
12. Elevated cyclin G2 expression intersects with DNA damage checkpoint signaling and is required for a potent G2/M checkpoint arrest response to doxorubicin.
Zimmermann M; Arachchige-Don AS; Donaldson MS; Dallapiazza RF; Cowan CE; Horne MC
J Biol Chem; 2012 Jun; 287(27):22838-53. PubMed ID: 22589537
[TBL] [Abstract][Full Text] [Related]
13. Checkpoint kinase 2 (Chk2) supports sensitivity to platinum-based treatment in high grade serous ovarian cancer.
Alkema NG; Tomar T; van der Zee AG; Everts M; Meersma GJ; Hollema H; de Jong S; van Vugt MA; Wisman GB
Gynecol Oncol; 2014 Jun; 133(3):591-8. PubMed ID: 24657486
[TBL] [Abstract][Full Text] [Related]
14. Sterigmatocystin-induced DNA damage triggers G2 arrest via an ATM/p53-related pathway in human gastric epithelium GES-1 cells in vitro.
Zhang D; Cui Y; Shen H; Xing L; Cui J; Wang J; Zhang X
PLoS One; 2013; 8(5):e65044. PubMed ID: 23705030
[TBL] [Abstract][Full Text] [Related]
15. The natural anticancer compound rocaglamide selectively inhibits the G1-S-phase transition in cancer cells through the ATM/ATR-mediated Chk1/2 cell cycle checkpoints.
Neumann J; Boerries M; Köhler R; Giaisi M; Krammer PH; Busch H; Li-Weber M
Int J Cancer; 2014 Apr; 134(8):1991-2002. PubMed ID: 24150948
[TBL] [Abstract][Full Text] [Related]
16. Differential DNA Damage Response of Peripheral Blood Lymphocyte Populations.
Felgentreff K; Schuetz C; Baumann U; Klemann C; Viemann D; Ursu S; Jacobsen EM; Debatin KM; Schulz A; Hoenig M; Schwarz K
Front Immunol; 2021; 12():739675. PubMed ID: 34594342
[TBL] [Abstract][Full Text] [Related]
17. Nuclear respiratory factor 1 overexpression attenuates anti-benzopyrene‑7,8-diol-9,10-epoxide-induced S-phase arrest of bronchial epithelial cells.
Wu J; Wang Y; Wo D; Zhang L; Li J
Mol Med Rep; 2016 May; 13(5):4372-8. PubMed ID: 27035420
[TBL] [Abstract][Full Text] [Related]
18. Planar compression of extracellular substrates induces S phase arrest via ATM-independent CHK2 activation.
Hayakawa K; Hirata H; Samsonov M; Sokabe M
Biochem Biophys Res Commun; 2018 Dec; 506(4):983-989. PubMed ID: 30404732
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus X protein activates the ATM-Chk2 pathway and delays cell cycle progression.
Kim S; Lee HS; Ji JH; Cho MY; Yoo YS; Park YY; Cha HJ; Lee Y; Kim Y; Cho H
J Gen Virol; 2015 Aug; 96(8):2242-2251. PubMed ID: 25872745
[TBL] [Abstract][Full Text] [Related]
20. Initiation of the ATM-Chk2 DNA damage response through the base excision repair pathway.
Chou WC; Hu LY; Hsiung CN; Shen CY
Carcinogenesis; 2015 Aug; 36(8):832-40. PubMed ID: 26025911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
